Commercial Scale API Production
ARTICLES
-
Spray Drying Enhances Solubility And Bioavailability Of Poorly Soluble Drugs
Over the last three decades, improved R&D has provided for modernized spray drying equipment to better meet the necessary requirements to produce powder with tailor-made properties for the end-user.
-
How A Leading Biopharma Manufacturer Is Re-Inventing Its CDMO Business
After establishing itself as a leading manufacturer of high purity biopharma components (i.e. supplying product to 6 of the top 10 billion dollar blockbuster biopharma drugs) and valued partner for custom API / HPAPI synthesis for over 80 years, Pfanstiehl became a wholly-owned subsidiary of the Ferro Corporation in 2001.
SUPPLIER PROFILES
-
Pharmaceutical Services & Active Ingredients (PSAI) & Global Generics and Proprietary Products
Dr. Reddy's offers a portfolio of products and services including APIs, Custom Pharmaceutical Services, Generics, Biosimilars, Differentiated Formulations and New Chemical Entities (NCEs).
-
Novasep
Novasep brings innovative solutions to complex challenges within the life science industries for the production of synthetic molecules and biomolecules.
-
Pharmatek Laboratories, Inc.
Pharmatek Laboratories, Inc. is a premier pharmaceutical chemistry development organization supporting the pharmaceutical and biotechnology industries.
-
PYRAMID Laboratories, Inc.
PYRAMID Laboratories, Inc. (PYRAMID), established in 1988, is located in Southern California, USA. Our facilities are housed in three (3) buildings covering approximately 70,000 sq. ft.
-
Recipharm AB
Recipharm is one of Europe’s leading pharmaceutical Contract Development and Manufacturing Organisations (CDMO).
SUPPLIERS
SERVICES
-
cGMP Manufacturing
Cedarburg Hauser Pharmaceuticals has the experience and capabilities to help you with either taking your API from the bench to market or simply take your existing process and generate the material you need for toxicity and clinical testing.
-
Semi-Solid & Liquid Manufacturing
DPT’s Center of Excellence for Semi-solids and Liquids is supported by in-house quality and microbiology labs, robust quality systems and a team of highly skilled technicians to support your manufacturing needs.
NEWS
-
CPhI Korea Launches As South Korea Commits To Extensive Drug Development Over Next 5 Years2/27/2014
Amsterdam: UBM Live has today announced the latest addition to its global pharmaceutical events portfolio, CPhI Korea 2014, which will take place on September 2nd-3rd 2014 at the COEX in Seoul, South Korea.
South Korea is now an undisputed member of the “developed pharmaceutical market” and home to the fastest growing industry within the developed ‘league’ according to IMS Health- which reported the Country’s double digit growth rate over the last 5-years and predicted a CAGR of 6.5% until 2015. Furthermore, South Korea is ideally located to attract key delegates and industry leaders from Japan, China, India and Hong Kong. The event will act as a centralised hub for regional drug manufacturers to meet with global suppliers of raw materials, machinery, packaging solutions and contract services, as well as attracting visitors from the region looking for suppliers and manufacturing partners to bring cost-competitive pharmaceuticals to their individual markets.